New device aims to ease painful birth scars without drugs
NCT ID NCT05345600
First seen Nov 19, 2025 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This study tests a device called MILTA, which uses light and magnetic fields, to reduce pain from perineal scars after childbirth. About 110 women with moderate to severe pain will receive either MILTA or a placebo treatment in two sessions. The goal is to see if this non-drug approach can help manage acute and chronic scar pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MILTA probe (light and magnetic therapy device)
What this could lead to
If it works, this could offer a non-drug option to ease pain from perineal scars after delivery.
What could go wrong
This is a small pilot study with only 110 participants, so results may not apply widely. The treatment is new for this use and may not reduce pain better than placebo.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.